iTeos Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-BlackRock, Inc.(10.6%)
iTeos Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-BlackRock, Inc.(10.6%)
iTeos Therapeutics | SC 13D/A:超过5%持股股东披露文件(修正)-Aaron I. Davis(8.1%),Boxer Capital Management, LLC(7.9%)等
iTeos Therapeutics | SC 13D/A:超过5%持股股东披露文件(修正)-Boxer Asset Management Inc.(0%),Joe Lewis(0%)
iTeos Therapeutics | SC 13G:超过5%持股股东披露文件-Tang Capital Management, LLC(6.6%),Kevin Tang(6.6%)等
iTeos Therapeutics | 4:持股变动声明-高管 Detheux Michel
iTeos Therapeutics | 4:持股变动声明-高管 Feltquate David
iTeos Therapeutics | 3:首次持股声明-高管 Feltquate David
iTeos Therapeutics | 4:持股变动声明-董事 Van Hauwermeiren Timothy
iTeos Therapeutics | 4:持股变动声明-董事 Ho Tony W
iTeos Therapeutics | 4:持股变动声明-董事 Lee David K
iTeos Therapeutics | 4:持股变动声明-董事 Davis Aaron I.
iTeos Therapeutics | 4:持股变动声明-董事 Hallal David
iTeos Therapeutics | 4:持股变动声明-董事 DeSimone Jill
iTeos Therapeutics | 4:持股变动声明-董事 RHOADS ANN D
iTeos Therapeutics | 4:持股变动声明-董事 Iannone Robert
iTeos Therapeutics | 4:持股变动声明- Boxer Capital, LLC
iTeos Therapeutics | SC 13D/A:超过5%持股股东披露文件(修正)-RA Capital Management, L.P.(9.99%),Peter Kolchinsky(9.99%)等
iTeos Therapeutics | 4:持股变动声明- RA CAPITAL MANAGEMENT, L.P.
iTeos Therapeutics | SC 13D/A:超过5%持股股东披露文件(修正)-Boxer Capital, LLC(8.1%),Boxer Asset Management Inc.(8.1%)等
暂无数据
暂无数据